Synthesis and structure-activity relationships of novel antiseptics
For the purpose of developing new antiseptics, we searched for compounds having high biocidal activity covering both gram-positive and gram-negative bacteria. Accordingly, we designed 1,5-disubstituted biguanides and synthesized them using two alternative efficient reaction schemes. The bactericidal activity of these biguanides was assayed by the micro titration plate method. Among the biguanides synthesized, 3,4-dichlorobenzyl derivatives were found to exhibit particularly high bactericidal activity. Ultimately, compound 11 was chosen as a candidate novel antiseptic, which is currently under continued evaluation.
References (18)
- et al.
Int. J. Pharm.
(1987) - et al.
Int. J. Pharm.
(1986) - et al.
Lancet
(1991) - et al.
Eur. J. Med. Chem.
(1991) - et al.
Chem. Pharm. Bull.
(1986) - et al.
Manufacturing Chemist.
(1958) - et al.
Yakugaku Zasshi
(1985) Infection (München)
(1986)- et al.
J. Org. Chem.
(1959)
Cited by (26)
Biguanides: Species with versatile therapeutic applications
2021, European Journal of Medicinal ChemistryCitation Excerpt :The antimicrobial activity of polymeric chlorhexidine release device was assessed in dentinal tubule infection using in vitro model of E. faecalis. The study suggested that this novel polymeric chlorhexidine-controlled release device can be effective medication against E. faecalis [463]. In 2012, Kim et al. compared the antimicrobial effectiveness of alexidine (1%) and chlorhexidine (2%) on dentin blocks infected by E. faecalis.
Olanexidine gluconate versus povidone-iodine for preventing surgical-site infection in orthopaedic surgery: A retrospective study
2019, Journal of Orthopaedic ScienceCitation Excerpt :Antiseptic solutions more effective than chlorhexidine and PVP-I for the SSI reduction are expected to be developed in the future years for orthopaedic surgeries. Olanexidine gluconate [1-(3,4-dichlorobenzyl)-5-octylbibuanide gluconate] (OLG) (Otsuka Pharmaceutical Factory, Tokushima, Japan) is a newly developed biguanide-based antiseptic for preoperative skin preparation, launched in Japan in 1997 [12], and has been available in clinical settings since 2015. OLG is a broader spectrum antiseptic compared to chlorhexidine or PVP-I [13,14].
The chemistry of biguanides: From synthetic routes to applications in organic chemistry
2020, Canadian Journal of ChemistryDermatitis caused by Olanedine (olanexidine gluconate) and povidone iodine
2019, Contact Dermatitis